metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Validation of stationary phases in 111In-pentetreotide planar chromatography
Journal Information
Vol. 32. Issue 5.
Pages 290-293 (September - October 2013)
Share
Share
Download PDF
More article options
Visits
1100
Vol. 32. Issue 5.
Pages 290-293 (September - October 2013)
Original article
Validation of stationary phases in 111In-pentetreotide planar chromatography
Validación de fases estacionarias en la cromatografía planar de 111In-pentetreótida
Visits
1100
E. Moreno-Ortega
Corresponding author
, L.M. Mena-Bares, F.R. Maza-Muret, F.J. Hidalgo-Ramos, J.A. Vallejo-Casas
Unidad de Gestión Clínica de Medicina Nuclear, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (4)
Table 1. Description of the quantitative variables: radiochemical purity and time of chromatographic development.
Table 2. Description of the quantitative variables: retention and resolution factors.
Table 3. Comparison of the means of radiochemical purity and the time of chromatographic development.
Table 4. Comparison of the means of the retention and resolution factors.
Show moreShow less
Abstract
Introduction

Since Pall-Gelman stopped manufacturing ITLC-SG, it has become necessary to validate alternative stationary phases.

Objective

To validate different stationary phases versus ITLC-SG Pall-Gelman in the determination of the radiochemical purity (RCP) of 111In-pentetreotide (111In-Octreoscan) by planar chromatography.

Material and methods

We conducted a case–control study, which included 66 111In-pentetreotide preparations. We determined the RCP by planar chromatography, using a freshly prepared solution of 0.1M sodium citrate (pH 5) and the following stationary phases: ITLC-SG (Pall-Gelman) (reference method), iTLC-SG (Varian), HPTLC silica gel 60 (Merck), Whatman 1, Whatman 3MM and Whatman 17. For each of the methods, we calculated: PRQ, relative front values (RF) of the radiopharmaceutical and free 111In, chromatographic development time, resolution between peaks. We compared the results obtained with the reference method. The statistical analysis was performed using the SPSS program. The p value was calculated for the study of statistical significance.

Results

The highest resolution is obtained with HPTLC silica gel 60 (Merck). However, the chromatographic development time is too long (mean=33.62min). Greater resolution is obtained with iTLC-SG (Varian) than with the reference method, with lower chromatographic development time (mean=3.61min). Very low resolutions are obtained with Whatman paper, essentially with Whatman 1 and 3MM. Therefore, we do not recommend their use.

Conclusions

Although iTLC-SG (Varian) and HPTLC silica gel 60 (Merck) are suitable alternatives to ITLC-SG (Pall-Gelman) in determining the RCP of 111In-pentetreotide, iTLC-SG (Varian) is the method of choice due to its lower chromatographic development time.

Keywords:
Pentetreotide
Octreoscan
Radiochemical purity
Instant thin layer chromatography-silica gel
Resumen
Introducción

Tras el cese en la fabricación de ITLC-SG por Pall-Gelman, es necesaria la validación de fases estacionarias alternativas.

Objetivo

Validar diferentes fases estacionarias frente a ITLC-SG de Pall-Gelman en la determinación de la pureza radioquímica (PRQ) de 111In-pentetreótida (111In-Octreoscan) por cromatografía planar.

Material y métodos

Realizamos un estudio caso-control en el que incluimos 66 preparaciones de 111In-pentetreótida. Determinamos la PRQ mediante cromatografía plana, empleando una solución recién preparada de citrato de sodio de 0,1M (pH 5) y las siguientes fases estacionarias: ITLC-SG (Pall-Gelman) (método de referencia), iTLC-SG (Varian), Silicagel 60 HPTLC (Merck), Whatman 1, Whatman 3MM y Whatman 17. Para cada uno de los métodos calculamos: PRQ, factores de retención (RF) del radiofármaco e 111In libre, tiempo de desarrollo cromatográfico y resolución entre picos. Comparamos los resultados obtenidos con los del método de referencia. Para el análisis estadístico de datos utilizamos el programa SPSS. Para el estudio de significación estadística calculamos el valor de p.

Resultados

Con Silicagel 60 HPTLC (Merck) se obtiene la mayor resolución, aunque el tiempo de desarrollo cromatográfico es prolongado (media=33,62min). Con iTLC-SG (Varian) se obtiene una resolución mayor que con el método de referencia, siendo menor el tiempo de desarrollo cromatográfico (media=3,61min). Con papel Whatman se obtienen resoluciones muy bajas, fundamentalmente con Whatman 1 y 3MM, por lo que no recomendamos su utilización.

Conclusiones

Aunque iTLC-SG (Varian) y Silicagel 60 HPTLC (Merck) son alternativas adecuadas a ITLC-SG (Pall-Gelman) en la determinación de la PRQ de 111In-pentetreótida, iTLC-SG (Varian) es el método de elección por su menor tiempo de desarrollo cromatográfico.

Palabras clave:
Pentetreótida
Octreoscan
Pureza radioquímica
Cromatografía de capa fina instantánea-gel de sílice

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos